Literature DB >> 12908038

[A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis].

Carmen Déa Ribeiro de Paula1, João Herman Duarte Sampaio, Danielle Rizzo Cardoso, Raimunda Nonata Ribeiro Sampaio.   

Abstract

Seventy-nine patients with cutaneous leishmaniasis were included in this study. The experimental group (n = 38) was treated with pentamidine isothionate in a dose of 4mg/kg/day on alternate days, for one week. The control group (n = 41) was treated with N-methylglucamine in a dose of 20mgSbV/kg/day for 20 days. Twenty-one isolates were identified using monoclonal antibody technique. We characterized Leishmania (Viannia) braziliensis, most frequently. There was a cure rate of 71.05% of the patients in the experimental group and 73.17% in the control group (p = 0.47). We found a statistical significance regarding frequency of ECG alterations between the experimental and control group (p<0.05). In our study pentamidine was as effective as antimonial for the treatment of american cutaneous leishmaniasis. It proved to be a safer drug considering heart toxicity. Moreover, it requires less time to complete the treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908038

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  10 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

3.  [Cutaneous leishmaniasis--an import from Belize].

Authors:  Jakob Schnedl; Herbert Auer; Marcellus Fischer; Herbert Tomaso; Tom Pustelnik; Gerhard Mooseder
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Drug resistance in leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  J Glob Infect Dis       Date:  2010-05

5.  STATUS OF THE AMERICAN TEGUMENTARY LEISHMANIASIS IN THE STATE OF RIO DE JANEIRO , BRAZIL, FROM 2004 TO 2013.

Authors:  Gilmar Ferreira Vita; Maria Angélica Vieira DA Costa Pereira; Ildemar Ferreira; Argemiro Sanavria; Celso Guimarães Barbosa; Rita de Cássia Martins Aurnheimer; Ericson Ramos de Mello; Claudia Bezerra da Silva; Rísia Brígida Gonçalves Cabral
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

6.  The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Authors:  Alexsandro Souza do Lago; Maurício Nascimento; Augusto M Carvalho; Neuza Lago; Juliana Silva; José Roberto Queiroz; Lucas P Carvalho; Albert Schriefer; Mary Wilson; Paulo Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

7.  Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).

Authors:  Erica de Camargo Ferreira E Vasconcellos; Maria Inês Fernandes Pimentel; Armando de Oliveira Schubach; Raquel de Vasconcellos Carvalhaes de Oliveira; Rilza Beatriz Azeredo-Coutinho; Fátima da Conceição Silva; Mariza de Matos Salgueiro; João Soares Moreira; Maria de Fátima Madeira; Cibele Baptista; Cláudia Maria Valete-Rosalino
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

8.  Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study.

Authors:  Sheila Viana Castelo Branco Gonçalves; Carlos Henrique Nery Costa
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

9.  Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study.

Authors:  Ellen Priscilla Nunes Gadelha; Sinésio Talhari; Jorge Augusto de Oliveira Guerra; Leandro Ourives Neves; Carolina Talhari; Bernardo Gontijo; Roberto Moreira da Silva Junior; Anette Chrusciak Talhari
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

10.  Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.

Authors:  Elisangela Oliveira Freitas; Dirlei Nico; Marcus Vinícius Alves-Silva; Alexandre Morrot; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2015-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.